Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Mixed Open; Ashtead Leads Gainers, Worldpay Losers

Wed, 07th Sep 2016 07:33

LONDON (Alliance News) - Stocks in London were mixed after the open on Wednesday, with Ashtead Group leading the blue-chip gainers after a well-received update, while Worldpay Group was the worst performer after private equity firms sold more shares than planned in the payments company.

The FTSE 100 index was down 1.08 points at 6,824.97. The FTSE 250 was down 0.2% at 17,965.33 and the AIM All-Share was up 0.2% at 799.26.

Ashtead rose 5.3%. The equipment rental company said the weakness of sterling following the UK's European Union membership vote will mean its full-year results are likely outpace its current expectations, as it said first quarter profit and revenue grew.

Ashtead, which makes most of its money in the US in dollars but reports its results in sterling, said pretax profit for the quarter to the end of July grew to GBP177.9 million, from GBP155.4 million a year earlier, while revenue increased to GBP707.1 million from GBP618.6 million.

Fellow FTSE 100 constituent Barratt Developments was up 1.8%. The housebuilder said its sales trend since the end of June had been encouraging and underpinned a "business-as-usual" stance following the Brexit decision, as it reported a 21% rise in pretax profit for its financial year.

Barratt hiked its final dividend to 12.30 pence per share up from 10.3p per share. This, together with a 12.40p per share special dividend and the interim dividend, meant the full-year dividend offered was 30.70p per share, up from 25.10p per share the prior year.

Gold miners Randgold Resources and Fresnillo were up 1.8% and 1.6%, respectively, tracking the precious metal's price higher. Gold was quoted at USD1,350.52 an ounce after the open, compared to USD1,339.59 an ounce at the European equities close on Tuesday.

A decline in the dollar on Tuesday against other major currencies following weak services data from the US boosted the oil price overnight, with Brent crude quoted at USD47.67 a barrel against USD46.81 on Tuesday.

Shares in Worldpay Group were down 3.8%, the worst blue-chip performer, after private equity firms Advent International and Bain Capital sold a larger-than-planned stake in the payments company. The transaction was first announced just after the London close on Tuesday, when BofA Merrill Lynch said the two investors were planning to sell 300.0 million Worldpay shares, or around a 15% stake, which eventually ended being 350.0 million shares.

Fund supermarket Hargreaves Lansdown said its chief executive will step down by the end of September 2017, as it reported growth in profit, net revenue and assets under administration in its financial year to the end of June. The stock was down 1.4%.

Hargreaves also said pretax profit for the year to June 30 grew 10% year-on-year to GBP218.9 million from GBP199.0 million a year prior. It will pay a second interim dividend of 16.30 pence per share, taking its total payout for the year to 34.00p, up 3.0% from the 33.0p payout a year before.

In the FTSE 250, Vectura Group was the biggest mid-cap performer, up 6.7%. The company, which primarily focuses on treatments for inhaled airways disease, raised its revenue expectations for the nine months to end December 31, thanks to its current strong trading performance.

At the other end of the index, CMC Markets was down 12%. The online retail trading firm said it has continued to make progress in its current financial year so far but said a lack of volatility in markets will hit its net operating income in the first half.

Investors will keep an eye this morning on UK manufacturing and industrial production data and Bank of England Governor Mark Carney's testimony to the Treasury Select Committee of Parliament.

Lloyds Bank analyst Nikesh Sawjani expects UK industrial production to show a 0.2% rise in July versus the 0.1% growth seen in June, while he expects manufacturing production to rise 0.5% from the 0.3% decline a month ago. The data are scheduled for 0930 BST.

At 1000 BST, Carney will lead testimony to the Treasury Select Committee, which is holding hearings on the August 4 Quarterly Inflation Report.

The BoE drastically downgraded its growth projections at the Inflation Report as the Leave vote in the EU referendum heightened uncertainty, and the sharp depreciation in sterling triggered an upward revision to the inflation forecast. In addition, UK interest rates were cut by 25 basis points to 0.25%, the first rate cut since 2009, amid other easing measures to reassure investor's confidence.

"Despite signs that the UK economy may be holding up well, we expect Carney and other Monetary Policy Committee colleagues to remain circumspect in their appearance before the Treasury Select Committee," said Sawjani.

"Although the initial impact of the EU referendum has been less negative than had been feared, policymakers are likely to defend the forecasts in the August Inflation Report, which pointed to expectations of a marked slowdown in economic growth in the second half of the year. As such, officials will keep open the possibility of a further reduction in Bank Rate, with November as the earliest likely opportunity," noted the analyst.

In mainland Europe, the CAC 40 index in Paris and the DAX 30 in Frankfurt were both up 0.1%.

In Asia on Wednesday, the Japanese Nikkei 225 index ended down 0.4%. In China, the Shanghai Composite rose 0.1%, while the Hang Seng index in Hong Kong continues down 0.2%.

Elsewhere in the economic calendar, UK Halifax house prices are at 0930 BST. In the US, the Redbook index is at 1355 BST, while JOLTS job openings are at 1500 BST. The Fed's Beige Book is at 1900 BST, while API weekly crude oil stock data are at 2130 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2018 12:53

hVIVO CEO Steps Down In Favour Of Executive Chair As Loss Narrows

LONDON (Alliance News) - Clinical development and drug discovery business hVIVO PLC said Thursday its loss narrowed in 2017 as Chief Executive Kym Denny stepped aside for Executive Chairman Trevor

Read more
3 Apr 2018 08:41

EUROPE RESEARCH ROUNDUP-Aevis Victoria, Martela Oyj, Mediaset

April 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aevis Victoria, Martela Oyj and Mediaset, on Tuesday. HIGHLIGHTS * Aevis SA

Read more
23 Mar 2018 18:23

DIRECTOR DEALINGS: Vectura Non-Executive Juliet Thompson Buys Shares

LONDON (Alliance News) - Vectura Group PLC said Friday Non-Executive Director Juliet Thompson bought shares worth GBP36,284 in the pharmaceutical company after

Read more
22 Mar 2018 16:16

DIRECTOR DEALINGS: Vectura Chairman, Non-Exec Director Buy Shares

LONDON (Alliance News) - Vectura Group PLC said on Thursday that two directors bought shares in the company on Wednesday.Chairman Bruno Angelici purchased 75,000 shares

Read more
21 Mar 2018 08:52

Vectura Delivers "Good" 2017 Results Despite Advair Disappointment

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said Wednesday it delivered a "good" set of 2017 results with underlying profit and revenue growth to

Read more
21 Mar 2018 08:31

UPDATE 1-UK's Vectura posts wider 2017 loss, revenue rise

March 21 (Reuters) - British drugmaker Vectura reported a worse-than-expected pretax loss for the full year on Wednesday, dragged by lower royalties and higher costs related to the SkyePharma for

Read more
21 Mar 2018 07:47

UPDATE 1-UK Stocks-Factors to watch on March 21

March 21 (Reuters) - Britain's FTSE 100 index is seen opening up 13 points on Wednesday, according to financial bookmakers, with futures 0.26 pct higher ahead of the cash

Read more
21 Mar 2018 07:40

Drugmaker Vectura's 2017 revenue rises 17.2 pct

March 21 (Reuters) - British drugmaker Vectura reported a 17.2 percent rise in 2017 revenue on Wednesday, aided by higher demand for its asthma products Flutiform and Ultibro. The company,

Read more
20 Mar 2018 13:21

Legal & General Increases Vectura Stake To 3.7% From Below 3% (ALLISS)

LONDON (Alliance News) - Vectura Group PLC said Tuesday FTSE 100-listed insurer and asset manager Legal & General Group PLC increased its stake in the pharmaceutical firm

Read more
14 Mar 2018 16:20

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 15 March Old MutualFull Year ResultsPhoenix GroupFull Year GroupFull 16

Read more
12 Mar 2018 10:43

WINNERS & LOSERS SUMMARY: Vectura And Hikma Hurt By US FDA Ruling

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------easyJet, up 2.3% at on

Read more
12 Mar 2018 09:43

FTSE 100 lags Europe on miners and energy, Just Eat goes cold

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Just Eat hit by DB downgrade * Vectura, Hikma hit by delay to Advair GKN up 12

Read more
16 Feb 2017 07:49

Vectura Hits GBP9 Million Royalty Cap Under Skyepharma Legacy Deal

Read more
16 Feb 2017 07:06

Vectura's GSK royalties agreements firing on all cylinders

(ShareCast News) - Vectura Group hit its royalty cap on sales of GlaxoSmithKline´s Ellipta range of products in 2016, one year ahead of forecasts. The cap was equivalent to £9.0m. The inhaled airways disease-focused business was also set to record £5.4m of 2016 revenues under a separate single digi

Read more
8 Feb 2017 13:49

UPDATE 1-Weak pound buoys GSK but drugmaker warns on 2017 generic threat

* 2017 core EPS seen flat-lower if mid-year generic Advair * Current exchange rates would lift 2017 sterling EPS 9 pct * Q4 2016 core EPS 26.1 pence vs consensus forecast 25.0p (Adds CEO comments, shares, background on new CEO) By Ben Hirschler LONDON, Feb 8 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.